Background-Activation of circulating monocytes in patients with acute coronary syndromes may reflect exposure to bacterial products or stimulation by cytokines such as IFN-␥. IFN-␥ induces phosphorylation and nuclear translocation of transcription factor STAT-1, which initiates a specific program of gene induction. To explore whether monocyte activation is IFN-␥ driven, patients with unstable (UA) or stable angina (SA) were compared for nuclear translocation of STAT-1 complexes and upregulation of IFN-␥-inducible genes CD64 and IP-10. Methods and Results-Peripheral blood mononuclear cells were stained for expression of CD64 on CD14 ϩ monocytes and analyzed by PCR for transcription of IP-10. Expression of CD64 was significantly increased in patients with UA. Monocytes from UA patients remained responsive to IFN-␥ in vitro, with accelerated transcriptional competency of CD64. IP-10 -specific sequences were spontaneously detectable in 82% of the UA patients and 15% of SA patients (PϽ0.001). Most importantly, STAT-1 complexes were found in nuclear extracts prepared from freshly isolated monocytes of patients with UA, which provides compelling evidence for IFN-␥ signaling in vivo.
T he pathogenesis of atherosclerosis is complex and includes contributions from multiple risk factors. 1 Among these, chronic inflammation is an important determinant. 2, 3 Monocytes/macrophages participate in several critical aspects of coronary artery disease. Macrophages phagocytose lipids and differentiate into foam cells, a process that has been implicated in subendothelial deposition of lipoproteins and plaque generation. 4 Macrophages also are known to be a component of cellular infiltrate in disrupted plaques that precipitate acute coronary thrombosis 5, 6 and may mediate tissue injury in unstable plaques through production of metalloproteinases. 7, 8 Circulating monocytes also have been found to be activated, particularly in patients with unstable angina (UA), which indicates a broader role of the innate immune system. 9 These monocytes are characterized by upregulation of adhesion molecules 10, 11 and increased production of cytokines 12, 13 and procoagulant substances. 14, 15 Through production of inflammatory mediators, activated monocytes contribute to the acute-phase response as reflected in laboratory tests such as that for elevated C-reactive protein. 16, 17 Mechanisms that lead to activation of circulating monocytes in patients with acute coronary syndromes are not known. Because these activated cells might contribute directly to the disease process, identification of stimulatory signals could provide clues to underlying processes and to the precise relationship between coronary events and inflammation.
Monocytes can be activated by a variety of stimuli; the most powerful activator is interferon (IFN)-␥. 18 Because the major sources of IFN-␥ are activated natural killer and T lymphocytes, inflammation in coronary artery disease may be a downstream effect of ongoing immune responses. We recently reported that the functional T-cell repertoire is altered in patients with UA. 19 Specifically, patients with unstable disease have an overrepresentation of CD4 T cells with high levels of intracellular IFN-␥, most which lack the costimulatory molecule CD28. CD4 ϩ CD28 null T cells are infrequent in patients with stable disease and in healthy controls but have undergone clonal proliferation in UA and infiltrate selectively into "culprit" coronary lesions. 19 The present study examined whether monocyte activation in patients with UA is triggered by IFN-␥. Binding of IFN-␥ to its receptor elicits a specific program of gene induction that targets genes with an IFN-␥-response element in the promoter region. 20 Triggering of the IFN-␥ receptor initiates a rapid signaling pathway in which Janus kinases (JAK) phosphorylate signal transducer and activator of transcription-1 (STAT-1) proteins. 21, 22 Homodimers of phosphorylated STAT-1 translocate to the nucleus and upregulate transcription of IFN-␥-responsive genes. Nuclear translocation of STAT-1 homodimers is characteristic of IFN-␥ triggering and is not seen with other activating stimuli or other cytokine receptors. STAT-1-regulated genes include CD64, the highaffinity receptor for IgG involved in phagocytosis and antigen capture, 23 and chemokine IP-10, which is chemotactic and stimulatory for T cells, natural killer cells, and monocytes. 24 Therefore, nuclear presence of STAT-1 and transcription of IP-10 and CD64 in monocytes of UA patients indicate IFN-␥ activity in vivo.
Methods Population
Thirty-six patients with stable angina (SA); 33 patients admitted to the Mayo Clinic Coronary Care Unit with a diagnosis of recent-onset UA, Braunwald class IIIB (Table) ; and 20 healthy age-matched individuals were included. Protocol was approved by the Mayo Clinic Internal Review Board, and all patients gave written informed consent.
SA patients had no acute events or worsening of symptoms during the prior 6 months and no anginal episodes during the week preceding enrollment. UA patients had experienced Ն2 episodes of angina at rest or 1 episode lasting Ͼ20 minutes during the preceding 48 hours, ST-segment shift diagnostic for myocardial ischemia during angina attacks, and no elevation in serum creatinine kinase on admission and during the first 24 hours of hospitalization. Patients with acute or chronic inflammatory diseases or a recent (Ͻ6 months) myocardial infarction, angioplasty, or heart failure were excluded.
Peripheral Blood Mononuclear Cell and Monocyte Isolation
Blood samples were drawn immediately on hospital admission. Monocytes were isolated from peripheral blood mononuclear cells (PBMC) by negative selection with a cocktail of hapten-conjugated antibodies and magnetic microbeads coupled to an anti-hapten monoclonal antibody (No-Touch monocyte isolation kit, Miltenyi Biotec) and depletion on a column in a magnetic field (VarioMACS, Miltenyi Biotec). In selected experiments, 1ϫ10 6 PBMC were incubated for 18 hours at 37°C with or without 200 U/mL IFN-␥ (BioSource International). 
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Reverse-Transcription PCR Analysis of IP-10 Expression
Total RNA of 5ϫ10 5 PBMC was extracted (TriZol, Life Technologies), and cDNA was amplified by reverse-transcription-polymerase chain reaction (RT-PCR). Nucleotide sequences (annealing temperature, amplification cycles) for 5Ј and 3Ј IP-10 primers, respectively, were as follows (GenBank NM_001565): GGAACCTCCAGTCT-CAGCACC and CAGCCTCTGTGTGGTCCATCC (53°C, 25 cycles). As a positive control, we used cDNA from 5ϫ10 5 PBMC stimulated for 90 minutes with increasing doses of IFN-␥ (100, 500, and 1000 U/mL). As an amplification control, ␤-actin was amplified with the following primers: 5Ј-ATCATGTTTGAGACCTTCAACA-CCCC and 3Ј-CAGGAGGAGCAATGATCTTGAT (GenBank M10277 and NM_001101, respectively).
Demographic and Clinical Characteristics
Nuclear Extracts and Mobility-Shift Assay
Nuclear extracts from 1ϫ10 7 PBMC or 1ϫ10 6 monocytes were prepared by use of a high-salt extraction protocol, and electrophoretic mobility shift assays were performed as described. 25 Nuclear extract (5 g) was combined with 15 L of binding buffer, 1.5 g of poly(dI-dC) (Sigma Chemical Co), and 1.5 g of nonspecific oligonucleotide (5Ј-TCGAAGTACTCAATTGCTCGAGATCGAT-AGATCTGAATTCAGTACTCC-3Ј). 26 In supershift assays, 1 g of a STAT-1␣-specific antibody (Transduction Laboratories) or irrelevant mouse IgG1 (Sigma) was added to the reaction. Total volume of reaction mixture was adjusted to 25 L, and mixture was left on ice for 30 minutes. Specific double-stranded oligonucleotide probe corresponding to sis-inducible element (CGCCATTTCCCGTA-AATC) 26, 27 was radiolabeled with [␥-32 P]ATP (NEN) by standard end-labeling reaction. Annealed probes at a final concentration of 40 fmol/L were added to the reaction and incubated at room temperature for 30 minutes. Protein-DNA complexes were resolved on 6% nondenaturing polyacrylamide gels and were detected by autoradiography. As a positive control, we used nuclear extracts from 1ϫ10 7 PBMC incubated for 30 minutes with 500 U/mL IFN-␥.
Statistical Analysis
Mann-Whitney U test (2 groups) and 
Results
Spontaneous Upregulation of CD64 on Circulating Monocytes of Patients With UA
CD64 expression on normal unstimulated monocytes is low but is highly responsive to IFN-␥. Figure 1 shows that CD64 expression on CD14 ϩ cells from patients with SA was indistinguishable from that of healthy age-matched controls. 
Hyperresponsiveness of Monocytes from UA Patients to IFN-␥ Stimulation
To examine responsiveness of monocytes to IFN-␥, we incubated PBMC with IFN-␥ for 18 hours. Induction of CD64 by IFN-␥ was a rapid process, and maximal surface levels were detected after 12 to 18 hours. Titration experiments demonstrated that 200 U/mL of IFN-␥ was optimal (data not shown). As shown in Figure 2 , exposure of PBMC to IFN-␥ promptly induced CD64 surface expression on monocytes from healthy controls and SA patients. Median fluorescence intensities increased to 99.9 and 112.5, respectively, equivalent to levels seen on unstimulated monocytes from patients with UA ( Figure 1) . Surprisingly, monocytes from patients with UA were not maximally stimulated. Once in vitro stimulation with IFN-␥ was administered, CD64 expression levels more than doubled, to a median fluorescence intensity of 266.6 ( Figure 2) . Differences in IFN-␥-induced CD64 expression were highly significant (Pϭ0.003, UA versus SA; PϽ0.001, UA versus controls). Baseline CD64 levels were strongly predictive of increased surface expression of CD64 induced by in vitro IFN-␥ (Figure 3 ), which suggests that CD64 gene transcription has been previously induced by in vivo IFN-␥ in UA patients and that this priming effect has led to enhanced responsiveness of the promoter on reexposure to in vitro IFN-␥.
Spontaneous Production of the IFN-␥-Induced Chemokine IP-10 in UA Patients
IP-10, an early-response gene of the CXC chemokine superfamily, is rapidly induced on signaling through the IFN-␥ Figure 1 . Expression of the IFN-␥-induced gene CD64 on circulating CD14 ϩ monocytes. Freshly isolated PBMC from patients with UA and SA and from age-matched healthy donors were immunostained with antibodies to CD14 and CD64 and analyzed by flow cytometry. For each donor, peak fluorescence of CD64 expression on CD14 ϩ monocytes was determined. Data are presented as box plots displaying 25th and 75th percentiles as boxes and 10th and 90th percentiles as whiskers. CD64 levels on circulating monocytes were spontaneously upregulated in UA (peak fluorescence intensity, 105.1) vs SA (peak fluorescence intensity, 67.4; Pϭ0.003) and controls (peak fluorescence intensity, 71.8; Pϭ0.008). Figure 1 . In all study cohorts, CD64 expression increased significantly after IFN-␥ stimulation. IFN-␥-induced CD64 expression was higher in UA (peak fluorescence intensity after IFN-␥ stimulation, 266.6) than in SA (112.5; Pϭ0.003) and controls (99.9; PϽ0.001).
receptor. 24 Freshly harvested PBMC from patients with UA or SA and from age-matched controls were assessed for transcription of IP-10 by RT-PCR. A strong signal for IP-10 was detected in 18 of 22 patients with UA, whereas only 3 of 20 patients with SA transcribed detectable amounts of IP-10 (PϽ0.001; Figure 4 ). No IP-10 -specific transcripts could be amplified from PBMC from healthy controls. Culture of these PBMC in presence of increasing amounts of IFN-␥ induced IP-10 gene activation; 1000 U/mL IFN-␥ was required to generate a signal equivalent to that spontaneously expressed by freshly isolated PBMC from patients with UA. These results demonstrated that both CD64 and IP-10 were transcriptionally activated in patients with UA.
STAT-1 Complexes in Nuclei of Freshly Isolated Monocytes From UA Patients
The link between IFN-␥ binding to its receptor on the cell surface and selective gene activation is phosphorylation and nuclear translocation of STAT-1. 21 Nuclear presence of STAT-1 complexes can be demonstrated in mobility shift assays. As shown in Figure 5 , nuclear extracts from UA patients contained proteins that formed complexes with the sis-inducible element oligonucleotide, which contains an IFN-␥-response element, 26, 27 and produced a characteristic gel-shift pattern. To confirm that proteins bound to the sis-inducible element probe were indeed STAT-1, gel supershifts with monoclonal antibodies to STAT-1␣ were performed. Shift in band migration was almost complete, which indicates that complexes consisted mostly, if not entirely, of STAT-1␣ homodimers. STAT-1 complexes were found exclusively in nuclear extracts from patients with UA. In 9 of 12 patients with UA, activated STAT-1 was detected. None of 11 patients with SA had nuclear translocated STAT-1. To identify the cell population with activated STAT-1, we separated monocytes from PBMC by a negative selection procedure, which avoids artificial activation of monocytes. Unseparated PBMC and negatively selected peripheral blood monocytes gave identical results for nuclear translocation of STAT-1 (data not shown). These findings provided additional support to the notion that in patients with UA, circulating monocytes had been exposed to in vivo IFN-␥ and had received a biologically relevant signal.
Discussion
Monocytes and macrophages are critical players in pathogenesis of atherosclerosis, particularly in patients with acute coronary syndromes. In the arterial wall lesion, they can mediate tissue injury and serve as accessory cells for T lymphocytes. Circulating monocytes that have upregulated cell surface receptors and produce proinflammatory mediators may contribute to plaque instability by increased cell adhesiveness and procoagulant activity and by influencing the functional state of endothelial cells. The most important outcome of the present study is that these activated monocytes have upregulated expression of IFN-␥-inducible genes and have translocated IFN-␥-specific transcription factor STAT-1. These findings led to the conclusion that monocyte/ macrophage activation in UA results, at least in part, from IFN-␥ signaling, which suggests a central role of T lymphocytes and adaptive immune responses. Monocytes/macrophages are cells of the innate immune system that provide immediate host responses against infections. Cell activation can be directly triggered by invading microorganisms, eg, by releasing cell wall component lipopolysaccharide, 28 -30 or can be induced by tissue injury or by several cytokines. 31 Tissue necrosis is an obvious candidate of monocyte activation in acute coronary syndromes. UA patients were selected to not have an elevated CK; however, 8 of 27 UA patients had elevated troponin levels, which indicated myonecrosis. Comparison of these 8 patients with the troponin-negative UA patients did not show any difference in monocyte activation markers IP-10 and CD64 (data not shown), which suggests that myonecrosis was not a major determinant in inducing these genes.
Among cytokines, IFN-␥, a product of T cells and natural killer cells, is a powerful stimulator for macrophages, driving them to maximal phagocytic capability, tissue invasiveness, and monokine release. The search for a molecular fingerprint of IFN-␥ action in freshly isolated monocytes was facilitated by accumulated knowledge of intracellular events after IFN-␥ stimulation. 22 Binding of IFN-␥ to its receptor activates a JAK-STAT signaling pathway involving JAK1, JAK2, and STAT-1. STAT-1 binds to the ligand-activated cytoplasmic portion of the IFN-␥ receptor, is phosphorylated by JAK, forms homodimers, and travels to the nucleus specifically to interact with regulatory elements referred to as IFN-␥ activation sites. Two genes that carry IFN-␥ activation site elements, CD64 and IP-10, were examined in the present study. Both genes were transcribed in monocytes freshly isolated from patients with UA, which suggests that these monocytes had been exposed to IFN-␥ in vivo. However, expression of these genes can be modified by the cytokines that could be active in vivo. Therefore, demonstration of nuclear translocation of STAT-1 complexes provided additional support to the interpretation that IFN-␥ was driving monocyte activation in vivo.
Level of upregulation of CD64 on the surface of monocytes in patients with UA was not maximal; in vitro culture with IFN-␥ further enhanced surface expression of CD64, which indicates that IFN-␥ stimulation in vivo was biologically significant but still could be increased. Interestingly, in vitro response to IFN-␥ was amplified in monocytes/macrophages of UA patients, which suggests a priming effect of in vivo IFN-␥ receptor triggering. In in vitro systems, combinatorial signals directed to the STAT-1 pathway have been demonstrated. 32, 33 One could find plausible that the primed state of circulating macrophages in UA makes them rapidly responsive to minor stimuli derived from additional IFN-␥ or other stimuli. These cells then easily would achieve maximal tissue-injurious capabilities. In such a setting, minor infections could precipitate a wave of monocyte/macrophage activity and possibly plaque instability. In essence, monocyte/ macrophage preactivation itself could represent a risk factor. Baseline activation state of the monocyte/macrophage system would determine degree to which the host reacts to an infectious stimulus, and patients with preactivated monocytes/macrophages would be at higher risk of overshooting inflammatory processes.
IFN-␥ can be produced by natural killer or T cells with stimulation. We recently have shown that IFN-␥ production by CD4 and CD8 T cells is increased in UA. 19 In particular, CD4 ϩ CD28 null T cells, known to produce large amounts of IFN-␥ without requirements for costimulation, 34 are expanded in UA. In vivo, CD64 expression correlated with frequencies of CD4 ϩ CD28 null T cells (Rϭ0.48; Pϭ0.006). Frequencies of CD4 ϩ CD28 null T cells also were predictive of IFN-␥-induced CD64 expression in vitro (Rϭ0.53; Pϭ0.002). Therefore, one could propose that macrophage activation in UA is a downstream effect of immune stimulation and is ultimately under T-cell control. Expansion of CD4 ϩ CD28 null T cells is not sufficient to explain monocyte activation, but T cells must be activated to generate IFN-␥. Although we recently have shown that expansion of CD4 ϩ CD28 null T cells is stable, activation may be intermittent, depending on antigenic exposure, and correlate with flares of monocyte activation and increased risk of instability.
Numerous activation markers for circulating monocytes from patients with UA have been reported. 10, 35 Additional knowledge Nuclear presence of STAT-1 protein was assessed by mobility shift assays in the presence of anti-STAT-1 monoclonal antibodies or isotype-matched control IgG antibodies. As a control, nuclear extracts were generated from 1ϫ10 7 PBMC incubated for 30 minutes with 500 U/mL IFN-␥. STAT-1 homodimers were detected in 9 of 12 UA patients (75%) but none of the SA patients (PϽ0.001). Data shown were reproducible in Ն3 independent experiments with nuclei from either unseparated PBMC or negatively isolated monocytes.
is gained by adding CD64 and IP-10 to that list. CD64 binds IgG with high affinity. By capturing immunocomplexes, CD64 is involved in antigen presentation; by facilitating antibodydependent cytotoxicity, it participates in cytolytic effector functions. Macrophages with high levels of CD64 have maximal capacity to ingest and kill microbes. 36 Also, CD64 has been identified as the predominant receptor for uptake of LDL by human macrophages. 37 Expression of IP-10 by macrophages conveys the ability to recruit T cells and monocytes actively into inflammatory lesions. 24 Recent reports have demonstrated tissue expression of IP-10 in human atherosclerotic plaque, 38, 39 which implicates this chemokine in regulation of plaque inflammation.
In conclusion, the present study provides evidence that patients with UA have circulating monocytes with a molecular fingerprint of IFN-␥ signaling in vivo. STAT-1 complexes were present in nucleus, and IFN-␥-inducible genes were upregulated. In addition, monocytes were primed for higher transcriptional competence of IFN-␥-responsive genes. Mechanisms bringing about maximal activation of macrophages may serve the host well when used to generate optimal responses against infectious agents. However, optimization of macrophage activation may pose a risk, because it amplifies tissue-destructive potential. Also, IFN-␥-primed monocytes may contribute directly to plaque injury. Correlation between presence of IFN-␥producing CD4 ϩ CD28 null T cells and in vivo monocyte/macrophage activation points toward immune dysregulation as a primary disease mechanism in coronary artery disease.
